SCHEDULE 13D - THE UMBRELLA PROJECT, L.L.C.

Company

Eloxx Pharmaceuticals, Inc.

Filed

May 7, 1999

Accession Number

0001015357-99-000068

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →